Swiss drugmaker Novartis AG is considering working with reinsurers to supply alternative financing options for life-saving drugs,potentially saving substantial healthcare costs, Financial Times reported on Sunday. Among the options proposed includes a “reinsurance model in which a third party …
Source: insurancejournal.com